BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18670852)

  • 21. Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.
    Teoh EJ; McGowan DR; Macpherson RE; Bradley KM; Gleeson FV
    J Nucl Med; 2015 Sep; 56(9):1447-52. PubMed ID: 26159585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-FDG PET/CT for staging of penile cancer.
    Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
    J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
    Wartski M; Le Stanc E; Gontier E; Vilain D; Banal A; Tainturier C; Pecking AP; Alberini JL
    Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.
    Akamatsu G; Mitsumoto K; Taniguchi T; Tsutsui Y; Baba S; Sasaki M
    Eur J Radiol; 2014 Jan; 83(1):226-30. PubMed ID: 24144448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
    Tian M; Yu L; Zhang Y; Gao X
    Acad Radiol; 2012 Apr; 19(4):420-6. PubMed ID: 22444673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
    Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
    J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
    AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT.
    Vogel WV; van Dalen JA; Schinagl DA; Kaanders JH; Huisman H; Corstens FH; Oyen WJ
    Nucl Med Commun; 2006 Jun; 27(6):515-9. PubMed ID: 16710106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phantom studies and clinical application of high resolution, image reconstruction using (18)F-fluoromethylcholine PET/CT for prostate cancer.
    Zielinski A; Behrendt FF; Verburg FA; Mottaghy FM; Krohn T
    Hell J Nucl Med; 2014; 17(3):194-9. PubMed ID: 25397625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of image reconstruction conditions with phantoms for brain FDG and amyloid PET imaging.
    Akamatsu G; Ikari Y; Nishio T; Nishida H; Ohnishi A; Aita K; Sasaki M; Sasaki M; Senda M
    Ann Nucl Med; 2016 Jan; 30(1):18-28. PubMed ID: 26337533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.
    Berthelsen AK; Holm S; Loft A; Klausen TL; Andersen F; Højgaard L
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1167-75. PubMed ID: 15909196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonpalpable supraclavicular lymph nodes in lung cancer patients: preoperative characterization with 18F-FDG PET/CT.
    Sung YM; Lee KS; Kim BT; Kim S; Kwon OJ; Choi JY; Yang SO
    AJR Am J Roentgenol; 2008 Jan; 190(1):246-52. PubMed ID: 18094319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of high-definition FDG-PET image reconstruction for lung cancer staging.
    Ozawa Y; Hara M; Shibamoto Y; Tamaki T; Nishio M; Omi K
    Acta Radiol; 2013 Oct; 54(8):916-20. PubMed ID: 23761556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters.
    Akamatsu G; Ishikawa K; Mitsumoto K; Taniguchi T; Ohya N; Baba S; Abe K; Sasaki M
    J Nucl Med; 2012 Nov; 53(11):1716-22. PubMed ID: 22952340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
    Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H
    Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin's lymphoma?
    Tsujikawa T; Otsuka H; Morita N; Saegusa H; Kobayashi M; Okazawa H; Nishitani H
    Ann Nucl Med; 2008 Jan; 22(1):23-30. PubMed ID: 18250984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.